HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

IART

Integra LifeSciences Holdings Corporation (Russell 2000)

Healthcare — Medical Devices

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Hold 2.7 / 5 9 analysts
$19.76
+$0.23 (+1.18%)
Target: $18.67 (-5.5%)
Sign in to add IART to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.54B
P/E Ratio (TTM)-
Forward P/E7.56
EPS (TTM)$-6.47
Dividend Yield-
Profit Margin-30.15%
Revenue Growth2.40%
ROE-38.63%
Debt/Equity195.79
Recommendation Hold 2.7
Analyst Target$18.67
Analysts9
Indexes Russell 2000

Technical Indicators

RSI (14)68.7
Beta1.22
SMA 20$18.66
SMA 40$18.03
52-Week High$20.49
52-Week Low$8.70
50-Day Avg$17.34
200-Day Avg$13.25
Avg Volume$1.05M
Volume$1.13M

Performance Analysis

NEUTRAL

IART presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($20.49), which may indicate limited upside.
+ RSI at 68.7 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 2.4% year-over-year.
- Operating at a loss with -30.1% margin.
~ Wall Street consensus is "Hold" from 9 analysts.
- Average analyst target of $18.67 implies 5.5% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:01 UTC

Back to Screener Export Report